Clinical Trial Update: Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluates the efficacy of bortezomib (Velcade) in patients with advanced Waldenstrom macroglobulinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenstrom Macroglobulinemia

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Waldenstrom Macroglobulinemia | Phase 2 | Status: COMPLETED